Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rapport Therapeutics (RAPP) Return on Equity (2024 - 2026)

Rapport Therapeutics (RAPP) has 3 years of Return on Equity data on record, last reported at 0.0% in Q1 2026.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity reached 0.0% in Q1 2026 per RAPP's latest filing, roughly flat from 0.0% in the prior quarter.
  • Over the last five years, Return on Equity for RAPP hit a ceiling of 0.01% in Q1 2024 and a floor of 0.0% in Q2 2024.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 define the central range for Return on Equity.
  • On a YoY basis, Return on Equity climbed as much as 0bps in 2025 and fell as far as -2bps in 2025.
  • Tracing RAPP's Return on Equity over 3 years: stood at 0.0% in 2024, then grew by 1bps to 0.0% in 2025, then dropped by 0bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for RAPP at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.